HPC – Becetamol (Propylene glycol)

The propylene glycol concentration following the administration of Becetamol Drops at the recommended dosage exceeds the defined thresholds for propylene glycol in neonates and children under 5 years

05.05.2023

In view of the health risks associated with high propylene glycol concentrations, Swissmedic declares that the product Becetamol Drops may no longer be used in children under 5 years.

Summary:

  • The propylene glycol concentration following the administration of Becetamol Drops at the recommended dosage exceeds the defined thresholds for propylene glycol in neonates and children under 5 years.
  • Becetamol Drops may no longer be administered to neonates or children under 5 years.

Detailed information can be found in the PDF document.